MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana and Psychedelics Industry News Stories Of The Week
Based on Positive Pre-IND Meeting With FDA, MindMed is Now Prepared to Open an Investigational New Drug (IND) in August 2021 With a Phase 2B Clinical Trial for LSD Assisted Therapy in Anxiety MindMed (OTCQB:MMEDF) announced the successful completion of a pre-IND (Investigational New Drug) meeting with the U.S. FDA regarding the development of LSD assisted therapy for an anxiety disorder. MindMed also provided a clinical development update on 18-MC announcing the firm continues to dose escalation of 18-MC in Phase I SAD/MAD and has confirmed a meeting with the FDA.
Source: benzinga.com